Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Aminolevulinic acid hydrochloride by Biofrontera for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval
Aminolevulinic acid hydrochloride is under clinical development by Biofrontera and currently in Phase II for Cutaneous Squamous Cell Carcinoma (cSCC)....